Your browser doesn't support javascript.
loading
Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine.
Matsumoto, Naomi; Kadowaki, Tomoka; Matsuo, Rumi; Sasaki, Ayako; Miyaji, Chikara; Higuchi, Chigusa; Nakayama, Masanori; Sakurada, Yasue; Hagiya, Hideharu; Takao, Soshi; Otsuka, Fumio; Yorifuji, Takashi.
Afiliação
  • Matsumoto N; Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
  • Kadowaki T; Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
  • Matsuo R; Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
  • Sasaki A; Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
  • Miyaji C; Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
  • Higuchi C; Okayama University Health Service Center.
  • Nakayama M; Okayama University Health Service Center.
  • Sakurada Y; Office of Innovative Medicine, Organization for Research Strategy and Development, Okayama University.
  • Hagiya H; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
  • Takao S; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
  • Otsuka F; Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
  • Yorifuji T; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
J Epidemiol ; 32(12): 567-569, 2022 12 05.
Article em En | MEDLINE | ID: mdl-36031363

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina de mRNA-1273 contra 2019-nCoV Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina de mRNA-1273 contra 2019-nCoV Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2022 Tipo de documento: Article
...